Table 3.
Outcomes and complications in ECMO
| Patients’ outcomes | All patients (n = 307) | Established (n = 229) | New (n = 78) | p value |
|---|---|---|---|---|
| Mortality on ECMO, n (%) | 128 (41.7) | 96 (41.9) | 32 (41) | 0.89 |
| Survive ECMO, n (%) | 178 (58) | 132 (57.6) | 46 (59) | 0.837 |
| Discharged home, n (%) | 138 (45) | 95 (41.5) | 43 (55.1) | 0.036 |
| ECMO duration in days median (IQR) | 15 (9.5–24) | 15 (9–24) | 15 (11–23) | 0.265 |
| Major bleeding | 73 (23.8) | 53 (23.1) | 20 (25.6) | 0.655 |
| Minor bleeding | 36 (11.7) | 25 (10.9) | 11 (14.1) | 0.45 |
| RF requiring RRT | 98 (31.9) | 73 (31.9) | 25 (32.1) | 0.977 |
| Cardiac arrest | 49 (16) | 38 (16.6) | 11 (14.1) | 0.604 |
| Infection | 214 (69.7) | 151 (65.9) | 63 (80.8) | 0.014 |
| Pneumothorax | 24 (7.8) | 18 (7.9) | 6 (7.7) | 0.962 |
| DVT | 2 (0.7) | 2 (0.9) | 0 | NA |
| PE | 15 (4.9) | 13 (5.7) | 2 (2.6) | 0.271 |
| Membrane lung failure | 29 (9.5) | 25 (10.9) | 4 (5.1 | 0.131 |
ECMO extracorporeal membrane oxygenation, RF renal failure, RRT renal replacement therapy, DVT deep venous thrombosis, PE pulmonary embolism